Meet Our Team

Rebecca Gwilt

Co-Founder & Managing Partner
Connect on LinkedIn 

Rebecca Gwilt launched Elevare Law to redefine legal partnerships for healthcare and technology innovators. With over a decade of experience advising pioneering digital health, AI, and virtual care companies, she blends deep regulatory expertise with a future-driven, business-first approach. From launch to exit, Rebecca provides strategic legal counsel that removes friction, mitigates risk, and accelerates growth.

Rebecca co-founded and led the country's first boutique healthcare innovation law firm for over a decade, guiding hundreds of companies through complex regulatory landscapes, helping them pivot, scale, innovate, and succeed. Prior to private practice, she worked with the U.S. Department of Health and Human Services (HHS) on the implementation of the Affordable Care Act and served as National Healthcare Policy Advisor at CGI, a global leader in health reform technology. These experiences shaped her commitment to legal counsel that is practical, proactive, policy-informed, and aligned with each client’s vision, budget, and goals.

At Elevare, Rebecca partners with healthcare visionaries, helping them anticipate challenges, seize opportunities, and build lasting impact. She believes legal should be more than risk management—it should be a catalyst for transformation.

Rebecca is also a passionate advocate for BIPOC and female founders, advising early stage companies, and mentoring startups through accelerators like Plug and Play, Texas Medical Center Innovations, and TechStars. A seeker of joy, investor in underestimated founders, karaoke samurai, expat adventurer, and kindness enthusiast, she lives in Lisbon, Portugal with her husband, three sons, and a playful bernedoodle named Sally.

Licensed In: Virginia

Check out these blogs written by 

Rebecca Gwilt

Legal + Regulatory
November 17, 2025
The CPOM Crackdown: Why Telemedicine Startups Should Be Watching State Laws Closely
"Wait—so our MSO model might not be legal in Oregon anymore?" That’s the question a founder of a multi-state telehealth platform asked after Oregon passed SB 951. And she wasn’t alone. Across boardrooms and VC Slack channels, healthcare operators are scrambling to decode a fast-moving regulatory trend: a nationwide wave of Corporate Practice of Medicine (CPOM) legislation.
AI + Health Tech
July 28, 2025
How America’s AI Action Plan Opens New Regulatory Flexibility for Digital Health Innovators
With the recent unveiling of America’s AI Action Plan, the U.S. government is putting AI innovation at the center of its economic, defense, and technological strategy. While the plan is geared toward government execution, its ripple effects for the private sector—especially digital health companies—are undeniable.
Legal + Regulatory
July 10, 2025
“So... Can We Still Use Meta Pixel?” Health Marketing After GoodRx, BetterHelp & the AHA (Partial) Victory
The CMO of a national telehealth network is excited. “We finally have a campaign people love—targeted content based on condition pages users visited. Can we scale it?”Her privacy officer winces. “Well... it depends. Did the user log in? Submit anything? Or just browse?”“No login. It’s our main web page. They just submit a form requesting more information,” the CMO replies. “All we have is an email address.”“Okay. Then maybe. But we’re still in that weird limbo thanks to OCR’s pixel guidance... even after the AHA lawsuit.”And just like that, the campaign’s on hold again.
Market Strategy
May 20, 2025
CMS Is Asking You How to Fix the Rules That Are Blocking Digital Health Innovation
You’ve seen this story before. Maybe it’s your story. A company builds a tech-enabled service for a high-need population—say, dual-eligible patients or those with multiple chronic conditions. ‍They develop a centralized platform that connects patients, primary care, specialists, and community supports. They streamline communication and workflows across fragmented providers.They reduce ER visits and hospital admissions with proactive, data-driven coordination.
AI + Health Tech
April 6, 2025
What the White House’s New AI Rules Teach Digital Health Companies About Building, Selling & Buying AI
Learn how digital health companies can use new federal AI guidance to strengthen compliance, improve procurement, and avoid risk. Insights from OMB Memos M-25-21 and M-25-22.
AI + Health Tech
April 6, 2025
Avoiding the AI Bullseye: How Digital Health Companies Can Navigate FTC Scrutiny and Shifting Federal Policy
FTC enforcement on AI is ramping up as federal policy shifts. Learn how digital health companies can avoid legal risk using NIST’s AI Risk Framework and recent enforcement case lessons.